Primary biliary cholangitis
Do you want to receive a message when there is new research about Primary Biliary Cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Primary Biliary Cholangitis. View what Premium costs.
Publications (1516)
- Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis. (2022/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Surgical Risk Assessment in Patients with Chronic Liver Diseases. (2022/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Skin Changes in Cirrhosis. (2022/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Experience with digital peroral cholangioscopy using SpyGlass DS in different reference centers in gastroenterology and digestive endoscopy in Colombia: Case series]. (2022/07/01) ♡
- UK-PBC National Audit: a collaborative success in identifying critical shortfalls. (2022/06/23) ♡
- A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion. (2022/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism (2022/06/01) ♡
- Bedside USG-Guided Paracentesis - A Technical Note for Beginners. (2022/05/27) ♡
- Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis. (2022/05/25) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism. (2022/05/23) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. RETRACTED: The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling. (2022/05/09) ♡
- Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis. (2022/05/01) ♡
- miR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis. (2022/05/01) ♡
- Usability of intraoperative cine-portogram during liver transplantation in young pediatric patients with biliary atresia. (2022/05/01) ♡
- Short-term preoperative drainage is associated with improved postoperative outcomes compared to that of long-term biliary drainage in pancreatic surgery. (2022/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-Related Sclerosing Cholangitis with Cholecystitis Mimicking Cholangiocarcinoma: A Case Report. (2022/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Value of Liver Function Tests in Cirrhosis. (2022/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Arterio-Biliary Fistula as a Rare Life-Threatening Complication of Transjugular Intrahepatic Portosystemic Shunt: A Case Report. (2022/05/01) ♡
- Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement. (2022/04/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Biological therapies in patients with liver disease: are they really lifesavers? (2022/04/01) ♡
- Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice. (2022/04/01) ♡
- Simplified 6-month prediction scores for primary biliary cholangitis patients treated with ursodeoxycholic acid. (2022/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cutting edge issues in juvenile sclerosing cholangitis. (2022/04/01) ♡
- Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies. (2022/04/01) ♡
- Upregulation of cadherin-11 contributes to cholestatic liver fibrosis. (2022/03/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development. (2022/03/11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial. (2022/03/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis. (2022/03/01) ♡
- Long term outcomes of hepatic resection following orthotopic liver transplant. (2022/03/01) ♡
- Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis. (2022/03/01) ♡
- Clinical Outcomes of Transcatheter Arterial Embolization Using N-Butyl-2-Cyanoacrylate (NBCA) in Cirrhotic Patients. (2022/03/01) ♡
- Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India. (2022/03/01) ♡
- Giant Cell Hepatitis in Copper Toxicosis. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatic Regeneration in Cirrhosis. (2022/03/01) ♡
- Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. (2022/03/01) ♡
- Comparative Evaluation of Anti-Fibrotic Effect of Tissue Specific Mesenchymal Stem Cells Derived Extracellular Vesicles for the Amelioration of CCl4 Induced Chronic Liver Injury. (2022/03/01) ♡
- Associations Between Autoimmune Conditions and Gastric Cancer Risk Among Elderly Adults in the United States. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Posttransplant immune-mediated cholangiopathies. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Familial Intrahepatic Cholestasis: Need for Genetic Analysis Before Liver Transplantation. (2022/03/01) ♡
- Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Center Experience in 91 Patients. (2022/03/01) ♡
- Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis. (2022/02/22) ♡
- Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis. (2022/02/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. (2022/02/03) ♡
- Diagnosis of liver cirrhosis with two-dimensional shear wave elastography in biliary atresia before Kasai portoenterostomy. (2022/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The need for early Kasai portoenterostomy: a Western Pediatric Surgery Research Consortium study. (2022/02/01) ♡
- Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. (2022/02/01) ♡
- Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]. (2022/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment. (2022/02/01) ♡
- The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B. (2022/02/01) ♡
- Feasibility of liver stiffness measured using two-dimensional shear wave elastography in assessing preoperative liver function for patients with hepatocellular carcinoma. (2022/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.